298 related articles for article (PubMed ID: 35390293)
41. Mucor in a Viral Land: A Tale of Two Pathogens.
Sen M; Lahane S; Lahane TP; Parekh R; Honavar SG
Indian J Ophthalmol; 2021 Feb; 69(2):244-252. PubMed ID: 33463566
[TBL] [Abstract][Full Text] [Related]
42. Successful outcome of disseminated mucormycosis in a 3-year-old child suffering from acute leukaemia: the role of isavuconazole? A case report.
Cornu M; Bruno B; Loridant S; Navarin P; François N; Lanternier F; Amzallag-Bellenger E; Dubos F; Mazingue F; Sendid B
BMC Pharmacol Toxicol; 2018 Dec; 19(1):81. PubMed ID: 30522521
[TBL] [Abstract][Full Text] [Related]
43. Two Uncommon Presentations of COVID-19-Associated Mucormycosis.
Rathna R; D'Souza C; D'Silva C; Joseph JM; Varghese AK
Cureus; 2022 Jan; 14(1):e21229. PubMed ID: 35186527
[TBL] [Abstract][Full Text] [Related]
44. [Mixed invasive fungal infection due to Rhizomucor pusillus and Aspergillus niger in an immunocompetent patient].
Pozo-Laderas JC; Pontes-Moreno A; Robles-Arista JC; Bautista-Rodriguez MD; Candau-Alvarez A; Caro-Cuenca MT; Linares-Sicilia MJ
Rev Iberoam Micol; 2015; 32(1):46-50. PubMed ID: 23583263
[TBL] [Abstract][Full Text] [Related]
45. Consensus recommendations for opioid agonist treatment following the introduction of emergency clinical guidelines in Ireland during the COVID-19 pandemic: A national Delphi study.
Durand L; Keenan E; Boland F; Harnedy N; Delargy Í; Scully M; Mayock P; Ebbitt W; Vázquez MO; Corrigan N; Killeen N; Pate M; Byrne P; Cousins G
Int J Drug Policy; 2022 Aug; 106():103768. PubMed ID: 35738029
[TBL] [Abstract][Full Text] [Related]
46. Isavuconazole: A New Broad-Spectrum Triazole Antifungal Agent.
Miceli MH; Kauffman CA
Clin Infect Dis; 2015 Nov; 61(10):1558-65. PubMed ID: 26179012
[TBL] [Abstract][Full Text] [Related]
47. Rhino-orbital mucormycosis: Our experiences with clinical features and management in a tertiary care center.
Singh SP; Rana J; Singh VK; Singh R; Sachan R; Singh S; Jain S
Rom J Ophthalmol; 2021; 65(4):339-353. PubMed ID: 35087975
[No Abstract] [Full Text] [Related]
48. Multidisciplinary approach in diagnosis and treatment of COVID-19-associated mucormycosis: a description of current reports.
Gogineni H; So W; Mata K; Greene JN
Egypt J Intern Med; 2022; 34(1):58. PubMed ID: 35911783
[TBL] [Abstract][Full Text] [Related]
49. The cost of treating mucormycosis with isavuconazole compared with standard therapy in the UK.
Bagshaw E; Kuessner D; Posthumus J; Escrig C; Blackney M; Heimann SM; Cornely OA
Future Microbiol; 2017 May; 12():515-525. PubMed ID: 28191796
[TBL] [Abstract][Full Text] [Related]
50. Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations.
Bayram N; Ozsaygılı C; Sav H; Tekin Y; Gundogan M; Pangal E; Cicek A; Özcan İ
Jpn J Ophthalmol; 2021 Jul; 65(4):515-525. PubMed ID: 34057620
[TBL] [Abstract][Full Text] [Related]
51. [Non-fatal disseminated mucormycosis in a solid organ transplant].
Minet C; Bonadona A; Tabah A; Karkas A; Mescam L; Schwebel C; Hamidfar R; Pison C; Saint-Raymond C; Faure O; Salameire D; Timsit JF
Rev Mal Respir; 2009 Nov; 26(9):998-1002. PubMed ID: 19953048
[TBL] [Abstract][Full Text] [Related]
52. COVID associated mucormycosis: A preliminary study from a dedicated COVID Hospital in Delhi.
Meher R; Wadhwa V; Kumar V; Shisha Phanbuh D; Sharma R; Singh I; Rathore PK; Goel R; Arora R; Garg S; Kumar S; Kumar J; Agarwal M; Singh M; Khurana N; Sagar T; Manchanda V; Saxena S
Am J Otolaryngol; 2022; 43(1):103220. PubMed ID: 34547717
[TBL] [Abstract][Full Text] [Related]
53. Drug repurposing of triazoles against mucormycosis using molecular docking: A short communication.
Mhatre S; Patravale V
Comput Biol Med; 2021 Sep; 136():104722. PubMed ID: 34358995
[TBL] [Abstract][Full Text] [Related]
54. COVID-19-Associated Mucormycosis in a Tertiary Care Hospital in India: A Case Series.
Singh S; Basera P; Anand A; Ozair A
Cureus; 2022 Aug; 14(8):e27906. PubMed ID: 36110469
[TBL] [Abstract][Full Text] [Related]
55. A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India.
Patel A; Kaur H; Xess I; Michael JS; Savio J; Rudramurthy S; Singh R; Shastri P; Umabala P; Sardana R; Kindo A; Capoor MR; Mohan S; Muthu V; Agarwal R; Chakrabarti A
Clin Microbiol Infect; 2020 Jul; 26(7):944.e9-944.e15. PubMed ID: 31811914
[TBL] [Abstract][Full Text] [Related]
56. Mucormycosis as SARS-CoV2 sequelae in kidney transplant recipients: a single-center experience from India.
Meshram HS; Kute VB; Chauhan S; Dave R; Patel H; Banerjee S; Desai S; Kumar D; Navadiya V; Mishra V
Int Urol Nephrol; 2022 Jul; 54(7):1693-1703. PubMed ID: 34792722
[TBL] [Abstract][Full Text] [Related]
57. Successful isavuconazole salvage therapy in a patient with invasive mucormycosis.
Ervens J; Ghannoum M; Graf B; Schwartz S
Infection; 2014 Apr; 42(2):429-32. PubMed ID: 24217961
[TBL] [Abstract][Full Text] [Related]
58. Mucormycosis: The Scathing Invader.
Vasudevan B; Hazra N; Shijith KP; Neema S; Vendhan S
Indian J Dermatol; 2021; 66(4):393-400. PubMed ID: 34759398
[TBL] [Abstract][Full Text] [Related]
59. Post-Covid Cerebral Mucormycosis, Varied Presentations and Surgical Strategies of a Newer Epidemic: An Institutional Experience.
Vijayasekhar MV; Nagappa V; Swaroop KH; Mithun G; Achuith E; Varaprasad KS
Neurol India; 2022; 70(3):1052-1056. PubMed ID: 35864638
[TBL] [Abstract][Full Text] [Related]
60. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium.
Cornely OA; Alastruey-Izquierdo A; Arenz D; Chen SCA; Dannaoui E; Hochhegger B; Hoenigl M; Jensen HE; Lagrou K; Lewis RE; Mellinghoff SC; Mer M; Pana ZD; Seidel D; Sheppard DC; Wahba R; Akova M; Alanio A; Al-Hatmi AMS; Arikan-Akdagli S; Badali H; Ben-Ami R; Bonifaz A; Bretagne S; Castagnola E; Chayakulkeeree M; Colombo AL; Corzo-León DE; Drgona L; Groll AH; Guinea J; Heussel CP; Ibrahim AS; Kanj SS; Klimko N; Lackner M; Lamoth F; Lanternier F; Lass-Floerl C; Lee DG; Lehrnbecher T; Lmimouni BE; Mares M; Maschmeyer G; Meis JF; Meletiadis J; Morrissey CO; Nucci M; Oladele R; Pagano L; Pasqualotto A; Patel A; Racil Z; Richardson M; Roilides E; Ruhnke M; Seyedmousavi S; Sidharthan N; Singh N; Sinko J; Skiada A; Slavin M; Soman R; Spellberg B; Steinbach W; Tan BH; Ullmann AJ; Vehreschild JJ; Vehreschild MJGT; Walsh TJ; White PL; Wiederhold NP; Zaoutis T; Chakrabarti A;
Lancet Infect Dis; 2019 Dec; 19(12):e405-e421. PubMed ID: 31699664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
